Literature DB >> 24995715

Disseminated Bacillus Calmette-Guérin (BCG) infection following allogeneic hematopoietic stem cell transplant in a patient with Bare Lymphocyte Syndrome type II.

R F Abu-Arja1, B E Gonzalez, M R Jacobs, L Cabral, R Egler, J Auletta, J Arnold, K R Cooke.   

Abstract

We describe the first case, to our knowledge, of disseminated Mycobacterium bovis Bacillus Calmette-Guérin infection in a child with Bare Lymphocyte Syndrome type II after undergoing hematopoietic stem cell transplantation (HSCT). The patient presented 30 days post HSCT with fever and lymphadenitis. Lymph node, blood, and gastric aspirates were positive for M. bovis. The patient received a prolonged treatment course with a combination of isoniazid, levofloxacin, and ethambutol. Her course was further complicated by granulomatous lymphadenitis and otitis media associated with M. bovis that developed during immune suppression taper and immune reconstitution. Ultimately, the patient recovered fully, in association with restoration of immune function, and has completed 12 months of therapy.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  BCG infection; Bare Lymphocyte Syndrome II; HSCT; Mycobacterium bovis; pediatric transplant

Mesh:

Substances:

Year:  2014        PMID: 24995715      PMCID: PMC4876699          DOI: 10.1111/tid.12263

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  37 in total

Review 1.  Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases.

Authors:  Sayna Norouzi; Asghar Aghamohammadi; Setareh Mamishi; Sergio D Rosenzweig; Nima Rezaei
Journal:  J Infect       Date:  2012-03-16       Impact factor: 6.072

Review 2.  Disseminated bacille Calmette-Guérin disease after vaccination: case report and review.

Authors:  E A Talbot; M D Perkins; S F Silva; R Frothingham
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

Review 3.  Important drug interactions in hematopoietic stem cell transplantation: what every physician should know.

Authors:  Brett Glotzbecker; Christine Duncan; Edwin Alyea; Bonnie Campbell; Robert Soiffer
Journal:  Biol Blood Marrow Transplant       Date:  2011-12-07       Impact factor: 5.742

4.  Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children.

Authors:  A C Hesseling; H Rabie; B J Marais; M Manders; M Lips; H S Schaaf; R P Gie; M F Cotton; P D van Helden; R M Warren; N Beyers
Journal:  Clin Infect Dis       Date:  2006-01-11       Impact factor: 9.079

5.  Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients.

Authors:  Monia Ouederni; Quentin B Vincent; Pierre Frange; Fabien Touzot; Sami Scerra; Mohamed Bejaoui; Aziz Bousfiha; Yves Levy; Barbara Lisowska-Grospierre; Danielle Canioni; Julie Bruneau; Marianne Debré; Stéphane Blanche; Laurent Abel; Jean-Laurent Casanova; Alain Fischer; Capucine Picard
Journal:  Blood       Date:  2011-09-08       Impact factor: 22.113

6.  Human leucocyte antigen-identical haematopoietic stem cell transplantation in major histocompatiblity complex class II immunodeficiency: reduced survival correlates with an increased incidence of acute graft-versus-host disease and pre-existing viral infections.

Authors:  Raffaele Renella; Capucine Picard; Bénédicte Neven; Marie Ouachée-Chardin; Jean-Laurent Casanova; Françoise Le Deist; Marina Cavazzana-Calvo; Stéphane Blanche; Alain Fischer
Journal:  Br J Haematol       Date:  2006-09       Impact factor: 6.998

7.  An intensive approach to the treatment of disseminated BCG infection in a SCID patient.

Authors:  A Ikincioğullari; F Doğu; E Ciftci; E Unal; M Ertem; I Reisli; S Adiyaman; S T Yildiran; S Erekul; E Babacan
Journal:  Bone Marrow Transplant       Date:  2002-07       Impact factor: 5.483

8.  Disseminated BCG infection in severe combined immunodeficiency presenting with severe anaemia and associated with gross hypersplenism after bone marrow transplantation.

Authors:  R Skinner; A L Appleton; M S Sprott; M R Barer; J G Magee; P J Darbyshire; M Abinun; A J Cant
Journal:  Bone Marrow Transplant       Date:  1996-05       Impact factor: 5.483

9.  Successful Handling of Disseminated BCG Disease in a Child with Severe Combined Immunodeficiency.

Authors:  Sílvia Bacalhau; Cristina Freitas; Rosalina Valente; Deolinda Barata; Conceição Neves; Katrin Schäfer; Annelie Lubatschofski; Ansgar Schulz; João Farela Neves
Journal:  Case Rep Med       Date:  2011-10-24

10.  A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis bacille Calmette-Guerin.

Authors:  Angela M Minassian; Iman Satti; Ian D Poulton; Joel Meyer; Adrian V S Hill; Helen McShane
Journal:  J Infect Dis       Date:  2012-04-01       Impact factor: 7.759

View more
  2 in total

1.  Serotype-Independent Protection Against Invasive Pneumococcal Infections Conferred by Live Vaccine With lgt Deletion.

Authors:  A-Yeung Jang; Ki Bum Ahn; Yong Zhi; Hyun-Jung Ji; Jing Zhang; Seung Hyun Han; Huichen Guo; Sangyong Lim; Joon Yong Song; Jae Hyang Lim; Ho Seong Seo
Journal:  Front Immunol       Date:  2019-05-29       Impact factor: 7.561

Review 2.  Tuberculosis in Pediatric Solid Organ and Hematopoietic Stem Cell Recipients.

Authors:  Melanie Dubois; Avika Dixit; Gabriella Lamb
Journal:  Glob Pediatr Health       Date:  2021-01-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.